Healthcare provider profile · identity verified

Eric Anthony Bloemer, MD

Allopathic & Osteopathic Physicians|Family Medicine · TEUTOPOLIS, IL · NPI 1073742664

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Eric Anthony Bloemer, MD received $18.90 in general payments during 2025 across 1 reported records.

Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 100 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Rybelsus by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$18.90

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$18.90	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$18.90	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$18.90	1	2025
Source payment records 2025-05-05 · Novo Nordisk Inc · $18.90 · Open Payments source
Rybelsus Normalized: rybelsus	Drug	Novo Nordisk Inc	$18.90	1	2025
Source payment records 2025-05-05 · Novo Nordisk Inc · $18.90 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Ozempic ozempic	2025	Ozempic	2024	100	exact normalized	Medicare Part D
Rybelsus rybelsus	2025	Rybelsus	2024	12 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	100	18
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	12	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1087	249
Metoprolol Succinate	Metoprolol Succinate	868	198
Lisinopril	Lisinopril	855	216
Levothyroxine Sodium	Levothyroxine Sodium	650	145
Eliquis	Apixaban	645	95
Omeprazole	Omeprazole	636	141
Amlodipine Besylate	Amlodipine Besylate	632	161
Furosemide	Furosemide	615	135
Warfarin Sodium	Warfarin Sodium	585	63
Potassium Chloride	Potassium Chloride	537	113
Pantoprazole Sodium	Pantoprazole Sodium	469	118
Montelukast Sodium	Montelukast Sodium	465	93
Rosuvastatin Calcium	Rosuvastatin Calcium	445	113
Metformin Hcl	Metformin Hcl	441	110
Carvedilol	Carvedilol	419	93
Tamsulosin Hcl	Tamsulosin Hcl	389	88
Losartan Potassium	Losartan Potassium	368	93
Gabapentin	Gabapentin	367	77
Simvastatin	Simvastatin	326	79
Duloxetine Hcl	Duloxetine Hcl	311	62
Allopurinol	Allopurinol	307	65
Clopidogrel	Clopidogrel Bisulfate	297	62
Glimepiride	Glimepiride	286	54
Pravastatin Sodium	Pravastatin Sodium	280	68
Metoprolol Tartrate	Metoprolol Tartrate	267	66
Hydrochlorothiazide	Hydrochlorothiazide	250	73
Sertraline Hcl	Sertraline Hcl	239	49
Spironolactone	Spironolactone	186	38
Meloxicam	Meloxicam	181	58
Escitalopram Oxalate	Escitalopram Oxalate	178	43
Donepezil Hcl	Donepezil Hcl	150	30
Januvia	Sitagliptin Phosphate	148	24
Tramadol Hcl	Tramadol Hcl	148	45
Citalopram Hbr	Citalopram Hydrobromide	147	34
Pregabalin	Pregabalin	139	23
Trazodone Hcl	Trazodone Hcl	135	34
Xarelto	Rivaroxaban	131	25
Valsartan	Valsartan	129	31
Isosorbide Mononitrate Er	Isosorbide Mononitrate	127	26
Hydralazine Hcl	Hydralazine Hcl	123	19
Jardiance	Empagliflozin	121	20
Esomeprazole Magnesium	Esomeprazole Magnesium	117	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	117	37
Amitriptyline Hcl	Amitriptyline Hcl	115	21
Fluticasone Propionate	Fluticasone Propionate	112	34
Albuterol Sulfate Hfa	Albuterol Sulfate	108	42
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	107	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	105	16
Mounjaro	Tirzepatide	104	18
Prednisone	Prednisone	102	72
Ozempic	Semaglutide	100	18
Metformin Hcl Er	Metformin Hcl	94	21
Pioglitazone Hcl	Pioglitazone Hcl	93	27
Famotidine	Famotidine	91	20
Finasteride	Finasteride	90	17
Celecoxib	Celecoxib	89	17
Glipizide	Glipizide	88	20
Atenolol	Atenolol	85	22
Shingrix	Varicella-Zoster Ge/As01b/Pf	77	54
Trulicity	Dulaglutide	76	13
Digoxin	Digoxin	75	22
Oxybutynin Chloride	Oxybutynin Chloride	75	13
Quetiapine Fumarate	Quetiapine Fumarate	75	suppressed
Bumetanide	Bumetanide	74	11
Fluoxetine Hcl	Fluoxetine Hcl	73	18
Cephalexin	Cephalexin	70	39
Diclofenac Sodium	Diclofenac Sodium	69	17
Lorazepam	Lorazepam	69	25
Ezetimibe	Ezetimibe	68	19
Venlafaxine Hcl Er	Venlafaxine Hcl	67	16
Novolog Flexpen	Insulin Aspart	63	13
Azithromycin	Azithromycin	61	57
Alprazolam	Alprazolam	60	11
Memantine Hcl	Memantine Hcl	59	13
Enalapril Maleate	Enalapril Maleate	57	12
Entresto	Sacubitril/Valsartan	55	suppressed
Mirtazapine	Mirtazapine	54	12
Synthroid	Levothyroxine Sodium	49	14
Clonazepam	Clonazepam	48	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	48	12
Humalog Kwikpen U-100	Insulin Lispro	48	suppressed
Sucralfate	Sucralfate	48	20
Amiodarone Hcl	Amiodarone Hcl	47	suppressed
Buspirone Hcl	Buspirone Hcl	47	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	47	36
Carbamazepine	Carbamazepine	46	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	45	45
Irbesartan	Irbesartan	45	12
Tresiba Flextouch U-200	Insulin Degludec	45	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	44	26
Lovastatin	Lovastatin	43	suppressed
Fluconazole	Fluconazole	42	34
Cefuroxime	Cefuroxime Axetil	41	36
Levetiracetam	Levetiracetam	41	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	12
Nifedipine Er	Nifedipine	41	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	40	suppressed
Dulera	Mometasone/Formoterol	40	suppressed
Creon	Lipase/Protease/Amylase	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	11
Clonidine Hcl	Clonidine Hcl	38	13
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Febuxostat	Febuxostat	37	suppressed
Glipizide Er	Glipizide	37	11
Terazosin Hcl	Terazosin Hcl	37	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Cholestyramine	Cholestyramine (With Sugar)	35	12
Bupropion Xl	Bupropion Hcl	34	suppressed
Propranolol Hcl Er	Propranolol Hcl	34	suppressed
Ventolin Hfa	Albuterol Sulfate	34	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	28
Myrbetriq	Mirabegron	31	suppressed
Baclofen	Baclofen	30	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Tradjenta	Linagliptin	30	suppressed
Tresiba Flextouch U-100	Insulin Degludec	30	suppressed
Colchicine	Colchicine	29	13
Farxiga	Dapagliflozin Propanediol	29	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	17
Risperidone	Risperidone	28	suppressed
Ondansetron Odt	Ondansetron	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Cefdinir	Cefdinir	26	24
Nitroglycerin	Nitroglycerin	26	17
Prolia	Denosumab	25	16
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Linzess	Linaclotide	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Colestipol Hcl	Colestipol Hcl	23	suppressed
Diazepam	Diazepam	23	suppressed
Nystatin	Nystatin	23	17
Verapamil Er	Verapamil Hcl	23	suppressed
Nebivolol Hcl	Nebivolol Hcl	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Ramipril	Ramipril	22	suppressed
Torsemide	Torsemide	22	suppressed
Amoxicillin	Amoxicillin	21	18
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	21	21
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Colesevelam Hcl	Colesevelam Hcl	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	11
Midodrine Hcl	Midodrine Hcl	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	19
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Divalproex Sodium	Divalproex Sodium	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	17
Levofloxacin	Levofloxacin	20	12
Lithium Carbonate	Lithium Carbonate	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Metolazone	Metolazone	18	suppressed
Mupirocin	Mupirocin	18	suppressed
Primidone	Primidone	18	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	12
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Metronidazole	Metronidazole	16	15
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	16	suppressed
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	11
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Bethanechol Chloride	Bethanechol Chloride	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Novolin R	Insulin Regular, Human	14	suppressed
Rivastigmine	Rivastigmine Tartrate	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Anastrozole	Anastrozole	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Estradiol	Estradiol	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Norethindrone	Norethindrone	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Dexamethasone	Dexamethasone	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Lithium Carbonate Er	Lithium Carbonate	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Nitroglycerin Patch	Nitroglycerin	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Propafenone Hcl Er	Propafenone Hcl	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Fluvastatin Er	Fluvastatin Sodium	11	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Levemir	Insulin Detemir	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$18.90 · 1 records	Novo Nordisk Inc	Ozempic, Rybelsus	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Ozempic play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error